-transparent.png){kind=logo}
The use of recombinant hepatitis B vaccines has led to the effective prevention of hepatitis B infection and its chronic sequelae in immunocompetent individuals. Whilst rare, a variety of serious adverse effects have been reported following vaccination including cutaneous vasculitis in eight previous cases. We describe a case of Henoch-Schönlein purpura developing after hepatitis B vaccination.
Related Publications
T Chave, and
C Neal, and
R Camp
August 2011,
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
T Chave, and
C Neal, and
R Camp
March 2009,
Archives of disease in childhood,
T Chave, and
C Neal, and
R Camp
March 2001,
Rheumatology (Oxford, England),
T Chave, and
C Neal, and
R Camp
September 1985,
American journal of diseases of children (1960),
T Chave, and
C Neal, and
R Camp
January 2011,
Revista da Sociedade Brasileira de Medicina Tropical,
T Chave, and
C Neal, and
R Camp
February 2007,
The Journal of dermatology,
T Chave, and
C Neal, and
R Camp
July 1984,
American journal of diseases of children (1960),
T Chave, and
C Neal, and
R Camp
August 1976,
Minerva pediatrica,
T Chave, and
C Neal, and
R Camp
June 1988,
British medical journal (Clinical research ed.),
T Chave, and
C Neal, and
R Camp
May 2001,
Pediatric nephrology (Berlin, Germany),
